Prescription Drug User Fee Act Patient-Focused Drug Development Initiative Commentary
ثبت نشده
چکیده
We are submitting commentary on behalf of Facing Our Risk of Cancer Empowered, also known as FORCE, which represents nearly a million people living with a BRCA genetic mutation in the U.S. We are also representing populations affected by Lynch Syndrome, Cowden Syndrome, Fanconi Anemia, Ataxia Telangiectasia, Li Fraumeni, and other hereditary cancer communities. Altogether, it is estimated that hereditary cancer syndromes affect over 2 million Americans.
منابع مشابه
The effects of different kinds of user fee on prescribing costs in rural Nepal.
OBJECTIVES (1) To estimate the cost of irrational prescribing, and (2) to compare the effect of three different kinds of user fee on prescribing costs, in rural Nepal. METHODS A controlled before-after study was conducted in 33 government primary health care facilities in rural eastern Nepal during 1992-95. A fee per prescription (covering all drugs in whatever amounts) was regarded as the co...
متن کاملThe Conundrum of Online Prescription Drug Promotion; Comment on “Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters”
This commentary discusses pertinent issues from Hyosun Kim’s paper on online prescription drug promotion. The study is well-designed and the findings highlight some of the consequences of the Food and Drug Administration’s (FDA’s) decision to deregulate online advertising of prescription drugs. While Kim’s findings confirm some of the early concerns, they also provide a perspective of implement...
متن کاملNew User Fee Agreements Aim at Ensuring Relief From High Drug Prices: But Trump's Budget Proposal Threatens to Upend Completed Negotiations.
The next iterations of the Generic Drug User Fee Act and the Biosimilar User Fee Act are meant to encourage new generic and biosimilar products, but higher fees and budget reductions may threaten progress.
متن کاملConsidering the Future of Pharmaceutical Promotions in Social Media; Comment on “Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters”
This commentary explores the implications of increased social media marketing by drug manufacturers, based on findings in Hyosun Kim’s article of the major themes in recent Food and Drug Administration (FDA) warning letters and notices of violation regarding online direct-to-consumer promotions of pharmaceuticals. Kim’s rigorous analysis of FDA letters over a 10-year span highlights a relative ...
متن کاملFDA Reform: Déjà Vu Encore
The Food and Drug Administration (FDA) creates the climate for the development of new drugs and clinical research. A 30 year struggle to bring drugs to the market more rapidly culminated in the 1992 Prescription Drug User Fee Act (PDUFA). While drug review times have shortened, concerns about drug safety possibly associated with more rapid reviews have led FDA and Congress to tighten safety req...
متن کامل